DSIP 5 MG

DSIP (Delta Sleep-Inducing Peptide) is a synthetic peptide derivative originally isolated from mammalian brain tissue. It has been developed as a stabilized analog for research purposes and is primarily studied in laboratory settings for its potential effects on sleep regulation, stress response, and peptide pharmacology. Preclinical studies have investigated DSIP in relation to experimental models of sleep disorders, stress modulation, and neuroendocrine regulation.

Research involving DSIP commonly explores:

• Its role in modulating sleep architecture and promoting natural sleep cycles in cellular and animal models.
• Possible contributions to the regulation of hypothalamic-pituitary-adrenal (HPA) axis activity and stress hormone levels.
• Experimental effects on pain perception, mood, and neuroendocrine function in controlled research systems.
• Its activity in studies of circadian rhythm, fatigue, and recovery processes, where its peptide sequence and stability are topics of interest.
DSIP is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.

Product details:

• Synonyms: Delta Sleep-Inducing Peptide, DSIP peptide
• Purity: ≥98%
• CAS Number: 62568-57-4
• Molecular Formula: C79H125N23O21
• Molecular Weight: Approximately 1560.96 Da
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.